New ML model shows importance of microbial load, as opposed to the more often used microbial composition, as a metric in ...

StitchR makes it possible to deliver larger payloads with current vectors, expanding the list of diseases targetable by gene therapies.

Glioblastoma (GBM) is the most common kind of malignant brain tumor in adults. In recent years, the tumor microenvironment ...

Innovative drug development "the flavor of 2025" says Ali Pashazadeh, who discusses how the new administration will likely ...

Engineered receptors could lead to more precisely targeted, effective cancer therapies with fewer side effects than existing ...

GEN webinar, experts from AbbVie and Benchling will share insights into the current tech landscape, AI readiness, and the ...

Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare disease targets.

SyVento says bringing the FlexFactory to Poland makes new therapies available to patients in an efficient and high-quality ...

Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

Researchers developed a high-throughput microfluidics-based method to measure and analyze lipids in single living cells using ...

Most discussion of gene and cell therapy costs focuses on increasing manufacturing efficiency but reducing costs can only go ...